Cargando…

The impact of SBF2 on taxane-induced peripheral neuropathy

Taxane-induced peripheral neuropathy (TIPN) is a devastating survivorship issue for many cancer patients. In addition to its impact on quality of life, this toxicity may lead to dose reductions or treatment discontinuation, adversely impacting survival outcomes and leading to health disparities in A...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cunningham, Geneva M., Shen, Fei, Wu, Xi, Cantor, Erica L., Gardner, Laura, Philips, Santosh, Jiang, Guanglong, Bales, Casey L., Tan, Zhiyong, Liu, Yunlong, Wan, Jun, Fehrenbacher, Jill C., Schneider, Bryan P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765656/ https://www.ncbi.nlm.nih.gov/pubmed/34986146 http://dx.doi.org/10.1371/journal.pgen.1009968

Ejemplares similares

Charcot-Marie-Tooth gene, SBF2, associated with taxane-induced peripheral neuropathy in African Americans
por: Schneider, Bryan P., et al.
Publicado: (2016)

A non-coding GWAS variant impacts anthracycline-induced cardiotoxic phenotypes in human iPSC-derived cardiomyocytes
por: Wu, Xi, et al.
Publicado: (2022)

Passage number affects differentiation of sensory neurons from human induced pluripotent stem cells
por: Cantor, Erica L., et al.
Publicado: (2022)

Cryotherapy for Prevention of Taxane-Induced Peripheral Neuropathy: A Meta-Analysis
por: Jia, Junting, et al.
Publicado: (2021)

“How is it going to help?”: Exploring Black breast cancer patients’ questions about biomarker testing to predict chemotherapy-induced peripheral neuropathy
por: Head, Katharine J., et al.
Publicado: (2022)

A Prospective Study of Taxane-Induced Neuropathy with Breast Cancer: Proper Assessment Tool for Taxane-Induced Neuropathy
por: Sohn, Eun Hee, et al.
Publicado: (2021)

Challenges and opportunities identifying therapeutic targets for chemotherapy-induced peripheral neuropathy resulting from oxidative DNA damage
por: Kelley, Mark R., et al.
Publicado: (2017)

Identifying Predictors of Taxane-Induced Peripheral Neuropathy Using Mass Spectrometry-Based Proteomics Technology
por: Chen, Emily I., et al.
Publicado: (2015)

Investigating the Effect of Zinc on the Prevention of Acute Peripheral Neuropathy in Cancer Patients Treated with Taxanes
por: Haji Gholami, Ali, et al.
Publicado: (2022)

A novel frameshift deletion in autosomal recessive SBF1-related syndromic neuropathy with necklace fibres
por: Gang, Qiang, et al.
Publicado: (2020)

Risk factors for chemotherapy‐induced peripheral neuropathy in patients receiving taxane‐ and platinum‐based chemotherapy
por: Molassiotis, Alex, et al.
Publicado: (2019)

Acupuncture for the Treatment of Taxane-Induced Peripheral Neuropathy in Breast Cancer Patients: A Pilot Trial
por: Jeong, Young Ju, et al.
Publicado: (2018)

Taxane-Induced Peripheral Neurotoxicity
por: Velasco, Roser, et al.
Publicado: (2015)

Melatonin, a Promising Role in Taxane-Related Neuropathy
por: Nahleh, Z., et al.
Publicado: (2010)

Safety and tolerability of cryocompression as a method of enhanced limb hypothermia to reduce taxane-induced peripheral neuropathy
por: Bandla, Aishwarya, et al.
Publicado: (2019)

A Multimodal Approach to Discover Biomarkers for Taxane-Induced Peripheral Neuropathy (TIPN): A Study Protocol
por: Sharma, Anukriti, et al.
Publicado: (2022)

Association of Taxane Type With Patient-Reported Chemotherapy-Induced Peripheral Neuropathy Among Patients With Breast Cancer
por: Mo, Hongnan, et al.
Publicado: (2022)

A biomarker of aging, p16, predicts peripheral neuropathy in women receiving adjuvant taxanes for breast cancer
por: Mitin, Natalia, et al.
Publicado: (2022)

Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients
por: Tanabe, Yuko, et al.
Publicado: (2020)

Incidence density and factors associated with peripheral neuropathy among women with breast cancer during taxane-based chemotherapy
por: Rattanakrong, Nida, et al.
Publicado: (2022)

A preliminary, prospective study of peripheral neuropathy and cognitive function in patients with breast cancer during taxane therapy
por: Ibrahim, Eiman Y., et al.
Publicado: (2022)

Diagnostic tools should be used for the diagnosis of chemotherapy induced peripheral neuropathy in breast cancer patients receiving taxanes
por: van Haren, Frank, et al.
Publicado: (2021)

Psychological distress and quality of life in breast cancer survivors with taxane-induced peripheral neuropathy: A scoping review
por: Schwab, Lauren, et al.
Publicado: (2023)

Overview of neuropathy associated with taxanes for the treatment of metastatic breast cancer
por: Rivera, Edgardo, et al.
Publicado: (2015)

Reliability and Validity of the Turkish Version of Chemotherapy-induced Peripheral Neuropathy Assessment Tool for Breast Cancer Patients Receiving Taxane Chemotherapy
por: Simsek, Neriman Yükseltürk, et al.
Publicado: (2018)

Cold Application and Exercise on Development of Peripheral Neuropathy during Taxane Chemotherapy in Breast Cancer Patients: A Randomized Controlled Trial
por: Şimşek, Neriman Yükseltürk, et al.
Publicado: (2021)

Correlates of Taxane-Induced Neuropathy, an Electronic Health Record Based Observational Study
por: Dorand, R. Dixon, et al.
Publicado: (2023)

Development of protocols for the first serial block-face scanning electron microscopy (SBF SEM) studies of bone tissue
por: Goggin, Patricia, et al.
Publicado: (2020)

Symptoms of anxiety but not depression before start of taxane-based chemotherapy are associated with peripheral neuropathy: a multicenter study in women with breast cancer
por: Verhoeff-Jahja, Rita, et al.
Publicado: (2022)

CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

Corrigendum: CYP3A genetic variation and taxane-induced peripheral neuropathy: a systematic review, meta-analysis, and candidate gene study
por: McEvoy, Laurence, et al.
Publicado: (2023)

The Fabrication of Biomimetic Chitosan Scaffolds by Using SBF Treatment with Different Crosslinking Agents
por: Liao, Chung-Tun, et al.
Publicado: (2010)

Emerging roles of a pivotal lncRNA SBF2-AS1 in cancers
por: Lu, Qian, et al.
Publicado: (2021)

Measurement properties of brief neuropathy screening items in cancer patients receiving taxanes, platinums, or proteasome inhibitors
por: Knoerl, Robert, et al.
Publicado: (2021)

Impact of taxanes on androgen receptor signaling
por: Bai, Shanshan, et al.
Publicado: (2019)

Adjuvant therapy of endometrial cancer: “taxane or not taxane, this is the question”
por: Lorusso, Vito, et al.
Publicado: (2019)

Peripheral Neuropathy as a Component of Skeletal Disease in Diabetes
por: Beeve, Alec T., et al.
Publicado: (2019)

“Fork and bracket” syndrome expands the spectrum of SBF1-related sensory motor polyneuropathies
por: Romani, Marta, et al.
Publicado: (2016)

Sex Differences in Taxane Toxicities
por: Chmielewski, Nicole N., et al.
Publicado: (2022)

Sbf/MTMR13 coordinates PI(3)P and Rab21 regulation in endocytic control of cellular remodeling
por: Jean, Steve, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_2nk4hfj5ajfr6dnm10asmkirud